HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Small interfering RNA targeting RelB protects against renal ischemia-reperfusion injury.

AbstractBACKGROUND:
Nuclear factor kappaB (NF-kappaB) has been found to be critical to the pathogenesis of renal ischemia-reperfusion injury (IRI). Using small interfering RNA (siRNA) to silence the expression of RelB, a component of the transcription factors Rel/nuclear factor kappaB, may protect renal IRI. Here, we report an siRNA-based treatment of preventing IRI.
METHODS:
Renal IRI was induced in mice by clamping the left renal pedicle for 25 or 35 min. The therapeutic effects of siRNA were evaluated in renal function, histologic examination, and overall survival after lethal IRI.
RESULTS:
A single injection of RelB siRNA resulted in knockdown of renal RelB expression. In comparison with control mice, levels of blood urea nitrogen and serum creatinine were significantly decreased in mice treated with siRNA. Pathologic examination demonstrated that tissue injury caused by IRI was markedly reduced as a result of RelB siRNA treatment. Additionally, with RelB siRNA treatment, immunohistochemistry showed a significant attenuation of tumor necrosis factor-alpha expression. Furthermore, survival experiments revealed that more than 90% of control mice died from lethal IRI, whereas 80% of siRNA-pretreated mice survived until the end of the 8-day observation period.
CONCLUSION:
Silencing RelB, using siRNA, can significantly attenuate IRI-induced renal dysfunction and protect mice against lethal kidney ischemia, highlighting the potential for siRNA-based clinical therapy.
AuthorsBiao Feng, Gang Chen, Xiufen Zheng, Hongtao Sun, Xusheng Zhang, Zhu-Xu Zhang, Ying Xiang, Thomas E Ichim, Bertha Garcia, Patrick Luke, Anthony M Jevnikar, Wei-Ping Min
JournalTransplantation (Transplantation) Vol. 87 Issue 9 Pg. 1283-9 (May 15 2009) ISSN: 1534-6080 [Electronic] United States
PMID19424026 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA Primers
  • RNA, Small Interfering
  • Relb protein, mouse
  • Transcription Factor RelB
  • Peroxidase
Topics
  • Animals
  • DNA Primers
  • Gene Silencing
  • Kidney (enzymology, pathology)
  • Male
  • Mice
  • Mice, Inbred Strains
  • Peroxidase (metabolism)
  • RNA, Small Interfering (genetics, therapeutic use)
  • Renal Circulation (physiology)
  • Reperfusion Injury (drug therapy, pathology, prevention & control)
  • Restriction Mapping
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transcription Factor RelB (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: